Partnering
Partnering with Komava
Building strategic partnerships to advance innovative therapies in regenerative wound care and dermatology.
Partnering opportunities
Working together across development and innovation.
Komava welcomes collaborations with biotechnology and pharmaceutical companies, research organisations and development partners that can accelerate the development and expansion of our therapeutic platform.
Komava is building a modular therapeutic platform with opportunities for collaboration across scientific development, manufacturing, clinical development and future therapeutic applications.
Scientific and technology collaborations
Collaborations supporting biomaterials, formulation, acellular regenerative payload development and other technologies that can strengthen or expand the Komava platform.
Development and manufacturing
Partnerships supporting process development, scale-up, manufacturing and the transition from lead optimisation through preclinical and clinical development.
Clinical collaborations
Collaborations with clinical experts, investigators and organisations with expertise in chronic wound care and dermatology.
Strategic partnerships
Business development, licensing and strategic collaborations to support pipeline development and explore new applications of the Komava platform.
Why partner with Komava
A modular platform with broader therapeutic potential.
A modular therapeutic platform
A scalable biomaterial-based platform designed to integrate indication-specific therapeutic payloads and support multiple therapeutic applications.
A focused development strategy
An initial focus on regenerative wound care, with neuroischemic diabetic foot ulcers as the lead programme and opportunities for expansion across chronic wounds and broader dermatology.
An experienced biotech team
A leadership team with extensive experience spanning biotechnology company building, CMC, manufacturing, regulatory development, clinical development and commercialisation.
A growing intellectual property portfolio
An intellectual property strategy designed to protect the platform, product compositions, manufacturing processes and therapeutic applications as development progresses.
Our partnering approach
The right expertise at the right stage.
Komava combines internal scientific and development expertise with selected external capabilities to advance its programmes efficiently.
We seek partners who bring complementary technologies, capabilities or expertise and share our ambition to develop differentiated therapies addressing significant unmet medical needs.
Detailed scientific and development information can be shared with prospective partners under appropriate confidentiality arrangements.
Let’s build the next generation of therapies together.
We welcome discussions with biotechnology and pharmaceutical companies, scientific collaborators, development organisations and investors interested in advancing the Komava platform.